182 related articles for article (PubMed ID: 91430)
1. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.
Sørensen PG; Rossing N; Rørth M
Eur J Respir Dis; 1985 May; 66(5):333-40. PubMed ID: 2410287
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
[TBL] [Abstract][Full Text] [Related]
4. The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.
Roncolato FT; Chatfield M; Houghton B; Toner G; Stockler M; Thomson D; Friedlander M; Gurney H; Rosenthal M; Grimison P;
Intern Med J; 2016 Aug; 46(8):893-8. PubMed ID: 27305276
[TBL] [Abstract][Full Text] [Related]
5. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
[TBL] [Abstract][Full Text] [Related]
6. Late pulmonary toxicity after treatment for Hodgkin's disease.
Villani F; De Maria P; Bonfante V; Viviani S; Laffranchi A; Dell'oca I; Dirusso A; Zanini M
Anticancer Res; 1997; 17(6D):4739-42. PubMed ID: 9494599
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function in children treated for rhabdomyosarcoma.
Kaplan E; Sklar C; Wilmott R; Michaels S; Ghavimi F
Med Pediatr Oncol; 1996 Aug; 27(2):79-84. PubMed ID: 8649324
[TBL] [Abstract][Full Text] [Related]
8. [Role of single-breath carbon monoxide-diffusing capacity in monitoring the bleomycin-induced lung toxicity in human].
Wang JL; Ma SQ; Zhang YJ; Han JN; Zhu YJ; Ma Y; Shen K; Li LY
Zhonghua Nei Ke Za Zhi; 2003 Oct; 42(10):709-12. PubMed ID: 14633466
[TBL] [Abstract][Full Text] [Related]
9. Changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study.
Jaén J; Vázquez G; Alonso E; León A; Guerrero R; Almansa JF
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1381-8. PubMed ID: 16757130
[TBL] [Abstract][Full Text] [Related]
10. The effect of tiotropium on the pulmonary diffusing capacity.
Gonlugur U
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary function assessment during bleomycin therapy.
Lampert-Benignus E; Eichler-Reiss F; Meunier-Carius J; Keiling R
Biomed Pharmacother; 1985; 39(2):87-93. PubMed ID: 2410052
[TBL] [Abstract][Full Text] [Related]
12. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume.
Johnson DC
Respir Med; 2000 Jan; 94(1):28-37. PubMed ID: 10714476
[TBL] [Abstract][Full Text] [Related]
13. [Changes in pulmonary function in SARS patients during the three-year convalescent period].
Liu YX; Ye YP; Zhang P; Chen J; Ye H; He YH; Li N
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):536-8. PubMed ID: 17767822
[TBL] [Abstract][Full Text] [Related]
14. The effect of corticosteroid administration on bleomycin lung toxicity.
Jensen JL; Goel R; Venner PM
Cancer; 1990 Mar; 65(6):1291-7. PubMed ID: 1689606
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
[TBL] [Abstract][Full Text] [Related]
16. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Aug; 88(2):405-10; discussion 410-1. PubMed ID: 19632384
[TBL] [Abstract][Full Text] [Related]
17. [Bleomycin and pulmonary function changes in children with malignant lymphomas].
Kuijten RR; Voûte PA; van Nierop JC; van Leeuwen EF; Griffioen RW; Wagner-Soeters RE
Ned Tijdschr Geneeskd; 1991 Feb; 135(6):225-8. PubMed ID: 1706483
[TBL] [Abstract][Full Text] [Related]
18. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors.
Ohashi T; Takeda A; Shigematsu N; Kunieda E; Ishizaka A; Fukada J; Deloar HM; Kawaguchi O; Takeda T; Takemasa K; Isobe K; Kubo A
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1003-8. PubMed ID: 15990001
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
20. Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study.
Samson MK; Stephens RL; Rivkin S; Opipari M; Maloney T; Groppe CW; Fisher R
Cancer Treat Rep; 1979; 63(9-10):1663-7. PubMed ID: 91435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
